News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,295 Results
Type
Article (13793)
Company Profile (101)
Press Release (252401)
Section
Business (88307)
Career Advice (465)
Deals (15408)
Drug Delivery (67)
Drug Development (36625)
Employer Resources (49)
FDA (6317)
Job Trends (6202)
News (150582)
Policy (14040)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (444)
Accelerated approval (2)
Adcomms (6)
Allergies (32)
Alliances (23276)
ALS (37)
Alzheimer's disease (406)
Antibody-drug conjugate (ADC) (37)
Approvals (6355)
Artificial intelligence (105)
Autoimmune disease (8)
Automation (3)
Bankruptcy (149)
Best Places to Work (4375)
BIOSECURE Act (9)
Biosimilars (55)
Biotechnology (40)
Bladder cancer (19)
Brain cancer (15)
Breast cancer (74)
Cancer (585)
Cardiovascular disease (70)
Career advice (407)
Career pathing (11)
CAR-T (21)
Cell therapy (85)
Cervical cancer (4)
Clinical research (30890)
Collaboration (326)
Compensation (139)
Complete response letters (17)
COVID-19 (757)
CRISPR (19)
C-suite (117)
Cystic fibrosis (35)
Data (606)
Denatured (15)
Depression (9)
Diabetes (77)
Diagnostics (1318)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (56)
Drug pricing (63)
Drug shortages (12)
Duchenne muscular dystrophy (33)
Earnings (32194)
Editorial (11)
Employer branding (4)
Employer resources (43)
Events (37602)
Executive appointments (360)
FDA (6721)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (210)
Gene editing (37)
Generative AI (8)
Gene therapy (99)
GLP-1 (339)
Government (1287)
Grass and pollen (2)
Guidances (15)
Healthcare (3582)
Huntington's disease (4)
IgA nephropathy (11)
Immunology and inflammation (34)
Indications (12)
Infectious disease (790)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (13)
Intellectual property (45)
Interviews (59)
IPO (5907)
IRA (29)
Job creations (2051)
Job search strategy (373)
Kidney cancer (6)
Labor market (10)
Layoffs (177)
Leadership (3)
Legal (3431)
Liver cancer (19)
Lung cancer (79)
Lymphoma (52)
Machine learning (1)
Management (16)
Manufacturing (143)
MASH (31)
Medical device (1498)
Medtech (1500)
Mergers & acquisitions (9702)
Metabolic disorders (246)
Multiple sclerosis (22)
NASH (14)
Neurodegenerative disease (24)
Neuropsychiatric disorders (6)
Neuroscience (581)
NextGen: Class of 2025 (1593)
Non-profit (603)
Northern California (683)
Now hiring (7)
Obesity (140)
Opinion (118)
Ovarian cancer (21)
Pain (50)
Pancreatic cancer (13)
Parkinson's disease (45)
Partnered (7)
Patents (104)
Patient recruitment (28)
Peanut (10)
People (28959)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8042)
Phase II (13067)
Phase III (11726)
Pipeline (415)
Podcasts (46)
Policy (59)
Postmarket research (1401)
Preclinical (3216)
Press Release (25)
Prostate cancer (44)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (158)
Real estate (2639)
Recruiting (17)
Regulatory (10103)
Reports (14)
Research institute (568)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (7)
Schizophrenia (35)
Series A (37)
Series B (13)
Service/supplier (3)
Sickle cell disease (31)
Southern California (698)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1631)
State (2)
Stomach cancer (3)
Supply chain (28)
Tariffs (10)
The Weekly (29)
United States (6960)
Vaccines (150)
Venture capitalists (13)
Webinars (10)
Weight loss (95)
Women's health (8)
Worklife (3)
Date
Today (46)
Last 7 days (277)
Last 30 days (982)
Last 365 days (12129)
2025 (3110)
2024 (12611)
2023 (14350)
2022 (19658)
2021 (20179)
2020 (19127)
2019 (14942)
2018 (11761)
2017 (13945)
2016 (13187)
2015 (15512)
2014 (12455)
2013 (10614)
2012 (11425)
2011 (11960)
2010 (10904)
Location
Africa (314)
Alabama (13)
Alaska (1)
Arizona (54)
Arkansas (3)
Asia (20112)
Australia (2626)
California (1650)
Canada (875)
China (230)
Colorado (66)
Connecticut (65)
Delaware (53)
Europe (39429)
Florida (307)
Georgia (36)
Idaho (9)
Illinois (187)
India (15)
Indiana (128)
Iowa (1)
Japan (86)
Kansas (55)
Kentucky (12)
Louisiana (1)
Maine (2)
Maryland (246)
Massachusetts (1440)
Michigan (47)
Minnesota (91)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (7)
New Hampshire (6)
New Jersey (725)
New Mexico (7)
New York (487)
North Carolina (380)
North Dakota (2)
Northern California (683)
Ohio (48)
Oklahoma (4)
Oregon (16)
Pennsylvania (425)
Puerto Rico (8)
Rhode Island (7)
South America (502)
South Carolina (2)
Southern California (698)
Tennessee (34)
Texas (222)
Utah (33)
Virginia (71)
Washington D.C. (29)
Washington State (112)
Wisconsin (14)
266,295 Results for "neurotech pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurotech’s ENCELTO™ (revakinagene taroretcel-lwey) Approved by the FDA for the Treatment of Macular Telangiectasia Type 2 (MacTel)
March 6, 2025
·
6 min read
Press Releases
Neurotech is Changing the Way We Treat Disease and Understand the Brain; Are Our Medical and Legal Institutions Ready?
The Dana Foundation Launches Neurotech Justice Accelerator at Mass General Brigham (NJAM) to Unite Science and Society and Mitigate Medical, Legal, and Ethical Risks
October 4, 2024
·
1 min read
Press Releases
Phantom Neuro Receives FDA Breakthrough Device and TAP Designations, Solidifying Position as a Neurotech Leader
March 6, 2025
·
3 min read
Press Releases
Motif Neurotech Wins UK Government Award to Develop Therapeutic Brain-Computer Interface
January 20, 2025
·
3 min read
Pharm Country
Neurotech Pharmaceuticals, Inc. Receives Priority Review of Biologics License Application (BLA) for NT-501 (revakinagene taroretcel) as a Treatment for Macular Telangiectasia Type 2 (MacTel)
Neurotech Pharmaceuticals, Inc. announces that the U.S. Food and Drug Administration (FDA), has determined that the Biologic License Application (BLA) for NT-501, an investigational encapsulated cell therapy for the treatment of MacTel, is sufficiently complete to permit a substantive review.
June 20, 2024
·
3 min read
Business
Alex Gorsky Joins Neurotech’s Board as Lead Director
Neurotech Pharmaceuticals, Inc., a private clinical stage biotech company, announced today that Alex Gorsky has been elected to Neurotech’s board as Lead Director.
September 13, 2023
·
3 min read
Press Releases
Neurotech Provides Update on BLA for NT-501 as a Treatment for Macular Telangiectasia Type 2 (MacTel)
November 8, 2024
·
2 min read
Press Releases
Neurotech Innovator UNEEG Medical Receives FDA Breakthrough Device Designation Within Monitoring and Diagnostic of Epilepsy
November 26, 2024
·
3 min read
Biotech Beach
Convergent Research Announces Major New Funding Commitment to Forest Neurotech
Convergent Research today announced a new $14 million funding commitment from former Google CEO Eric Schmidt to Forest Neurotech, an initiative designed to create next-generation brain-computer-interfaces (BCIs) for individuals with neurological injuries or diseases.
March 11, 2024
·
2 min read
Lone Star Bio
Motif Neurotech Raises $18.75 Million in Series A Financing to Advance Implantable Device for Treatment-Resistant Depression
Motif Neurotech announced today an oversubscribed Series A financing of $18.75 million led by Arboretum Ventures.
January 24, 2024
·
3 min read
1 of 26,630
Next
